Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2021 Mar 8;11(1):5369.
doi: 10.1038/s41598-021-84723-7.

Key factors in a rigorous longitudinal image-based assessment of retinopathy of prematurity

Affiliations
Clinical Trial

Key factors in a rigorous longitudinal image-based assessment of retinopathy of prematurity

Tatiana R Rosenblatt et al. Sci Rep. .

Abstract

To describe a database of longitudinally graded telemedicine retinal images to be used as a comparator for future studies assessing grader recall bias and ability to detect typical progression (e.g. International Classification of Retinopathy of Prematurity (ICROP) stages) as well as incremental changes in retinopathy of prematurity (ROP). Cohort comprised of retinal images from 84 eyes of 42 patients who were sequentially screened for ROP over 6 consecutive weeks in a telemedicine program and then followed to vascular maturation or treatment, and then disease stabilization. De-identified retinal images across the 6 weekly exams (2520 total images) were graded by an ROP expert based on whether ROP had improved, worsened, or stayed the same compared to the prior week's images, corresponding to an overall clinical "gestalt" score. Subsequently, we examined which parameters might have influenced the examiner's ability to detect longitudinal change; images were graded by the same ROP expert by image view (central, inferior, nasal, superior, temporal) and by retinal components (vascular tortuosity, vascular dilation, stage, hemorrhage, vessel growth), again determining if each particular retinal component or ROP in each image view had improved, worsened, or stayed the same compared to the prior week's images. Agreement between gestalt scores and view, component, and component by view scores was assessed using percent agreement, absolute agreement, and Cohen's weighted kappa statistic to determine if any of the hypothesized image features correlated with the ability to predict ROP disease trajectory in patients. The central view showed substantial agreement with gestalt scores (κ = 0.63), with moderate agreement in the remaining views. Of retinal components, vascular tortuosity showed the most overall agreement with gestalt (κ = 0.42-0.61), with only slight to fair agreement for all other components. This is a well-defined ROP database graded by one expert in a real-world setting in a masked fashion that correlated with the actual (remote in time) exams and known outcomes. This provides a foundation for subsequent study of telemedicine's ability to longitudinally assess ROP disease trajectory, as well as for potential artificial intelligence approaches to retinal image grading, in order to expand patient access to timely, accurate ROP screening.

PubMed Disclaimer

Conflict of interest statement

T.R. Rosenblatt, None; M.H. Ji, None; D. Vail, None; C.A. Ludwig, None; A. Al-Moujahed, None; M. Veerappan Pasricha, None; N.F. Callaway, None; J. Kumm, Pr3vent INC (F,CEO); D.M. Moshfeghi, 1-800Contacts (BOD,E), Akceso Advisors AG (C), Akebia (SAB), Alcon (C), Aldeyra Therapeutics (PI), Alexion (C), Allegro (SAB), Apellis (PI), Bayer Pharma AG (SC,C), CMEOutfitters.com (C), Congruence Medical Solutions (C), dSentz, Inc. (F,E,BOD), Grand Legend Technology, LTD (E), Iconic Therapeutics (SC), Irenix (SAB), Linc (F,E,BOD), M3 Global Research (C), Northwell Health (C), Novartis Pharmaceuticals (DMC, C), Ocular Surgery News (C), Pr3vent INC (F,E,BOD), Praxis UNS, Inc. (C), Prime Medical Education (C), Promisight, Inc (F, E, BOD), Pykus (E,SAB), Regeneron (SC,PI), Retina Technologies LLC (SAB,C,E), Retina Today/Pentavision (C), Shapiro Law Group (C), SLACK, Inc (C), Versl, Inc. (F E), Vindico (C), Visunex (E,SAB).

Figures

Figure 1
Figure 1
Right eye central view images from four consecutive weeks in two different patients (first patient: (AD), second patient: (EH)). (AD) Continually worsening vascular tortuosity and overall worsening ROP by gestalt scores. (EH) Stable vascular tortuosity and no overall progression of ROP by gestalt scores.

Similar articles

Cited by

References

    1. Flynn JT. Retinopathy of prematurity. Pediatr. Clin. N. Am. 1987;34:1487–1516. doi: 10.1016/S0031-3955(16)36370-2. - DOI - PubMed
    1. Blencowe H, Lawn J, Vazquez T, Fielder A, Gilbert C. Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010. Pediatr. Res. 2013;74:35–49. doi: 10.1038/pr.2013.205. - DOI - PMC - PubMed
    1. Connor AO, Fielder AR. Long term ophthalmic sequelae of prematurity. Early Hum. Dev. 2008;84:101–106. doi: 10.1016/j.earlhumdev.2007.11.005. - DOI - PubMed
    1. Hartnett M, Penn J. Mechanisms and management of retinopathy of prematurity. N. Engl. J. Med. 2012;367:2515–2526. doi: 10.1056/NEJMra1208129. - DOI - PMC - PubMed
    1. Lad E, Hernandez-Boussard T, Morton J, Moshfeghi D. Incidence of retinopathy of prematurity in the United States: 1997 through 2005. Am. J. Ophthalmol. 2009;148:451–458. doi: 10.1016/j.ajo.2009.04.018. - DOI - PubMed

Publication types